NCT05580744

Brief Summary

In the proposed study, the investigators assumed that mirror therapy combined with augmented reality technology will provide a better treatment effects than traditional mirror therapy for the patients with unilateral stroke. The aim of the study is to examine the difference in the treatment effects among the combination of task-oriented training with either augmented reality based mirror therapy, mirror therapy or traditional occupational therapy on the upper extremity function and brain activity of the stroke patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
Completed

Started Jan 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 6, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 14, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

January 3, 2023

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 8, 2024

Completed
19 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 27, 2024

Completed
Last Updated

December 16, 2024

Status Verified

November 1, 2023

Enrollment Period

1.3 years

First QC Date

October 6, 2022

Last Update Submit

December 11, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in the result of Fugl-Meyer assessment (FMA) for motor function of upper extremity test

    Each item is rated on a three-point ordinal scale (2 points for the detail being performed completely, 1 point for the detail being performed partially, and 0 for the detail not being performed). The maximum motor performance score is 66 points for the upper extremity.

    baseline, 9 weeks and 21 weeks

Secondary Outcomes (4)

  • Change in the result of Modified Ashworth scale (MAS)

    baseline, 9 weeks and 21 weeks

  • Change in the result of Box and blocks test

    baseline, 9 weeks and 21 weeks

  • Change in the result of Semmes-Weinstein monofilament (SWM) test

    baseline, 9 weeks and 21 weeks

  • Change in the result of Motor Activity Log

    baseline, 9 weeks and 21 weeks

Other Outcomes (1)

  • changes in oxygenated (HbO) and deoxygenated (Hb) hemoglobin concentrations using near infrared spectroscopy (NIRS)

    baseline, 9 weeks and 21 weeks

Study Arms (3)

Traditional occupational therapy

ACTIVE COMPARATOR

Traditional occupational therapy delivered skill training related to daily living tasks.

Other: Traditional occupational therapy

Mirror therapy using a mirror box

ACTIVE COMPARATOR

Exercise of mirror therapy included movements of forearm, wrist, fingers and thumb, as well as a tendon gliding exercise using a mirror box .

Other: Mirror therapy using a mirror box

Augmented reality-based mirror therapy

EXPERIMENTAL

Exercise of augmented reality-based mirror therapy included movements of forearm, wrist, fingers and thumb, as well as a tendon gliding exercise using an augmented reality mirror therapy system .

Other: Augmented reality-based mirror therapy

Interventions

Motor training targeted to goals that are relevant to the functional needs of the patient

Traditional occupational therapy

Mirror therapy using a mirror box

Mirror therapy using a mirror box

Augmented reality-based mirror therapy

Augmented reality-based mirror therapy

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical diagnosis of stroke with unilateral side involved;
  • A score of Mini-mental state examination greater than 24 for proving higher mental function
  • Time of onset \> 6 months before treatment begins; and
  • Premorbid right-handedness.

You may not qualify if:

  • Severe vision impairment;
  • Major cognitive-perceptual deficit;
  • Other brain disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Cheng-Kung University Hospital

Tainan, Taiwan, 704, Taiwan

Location

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 6, 2022

First Posted

October 14, 2022

Study Start

January 3, 2023

Primary Completion

May 8, 2024

Study Completion

May 27, 2024

Last Updated

December 16, 2024

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations